Katarzyna Guzik

2.3k total citations · 1 hit paper
21 papers, 1.9k citations indexed

About

Katarzyna Guzik is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Katarzyna Guzik has authored 21 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Immunology. Recurrent topics in Katarzyna Guzik's work include Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (4 papers) and Phagocytosis and Immune Regulation (4 papers). Katarzyna Guzik is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), CAR-T cell therapy research (4 papers) and Phagocytosis and Immune Regulation (4 papers). Katarzyna Guzik collaborates with scholars based in Poland, Netherlands and Germany. Katarzyna Guzik's co-authors include Tad A. Holak, Alexander Dömlingꝉ, Grzegorz Dubin, Bogdan Musielak, Krzysztof M. Żak, P. Grudnik, Katarzyna Magiera‐Mularz, Radosław Kitel, Przemysław Golik and Sara Przetocka and has published in prestigious journals such as Journal of Medicinal Chemistry, Infection and Immunity and Cell Death and Differentiation.

In The Last Decade

Katarzyna Guzik

21 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1

2015 413 citations Krzysztof M. Żak, Radosław Kitel et al. Structure profile →

Peers

Countries citing papers authored by Katarzyna Guzik

Since Specialization

Citations

This map shows the geographic impact of Katarzyna Guzik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katarzyna Guzik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katarzyna Guzik more than expected).

Fields of papers citing papers by Katarzyna Guzik

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katarzyna Guzik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katarzyna Guzik. The network helps show where Katarzyna Guzik may publish in the future.

Co-authorship network of co-authors of Katarzyna Guzik

This figure shows the co-authorship network connecting the top 25 collaborators of Katarzyna Guzik. A scholar is included among the top collaborators of Katarzyna Guzik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katarzyna Guzik. Katarzyna Guzik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Ultrasensitive electrochemical determination of the cancer biomarker protein sPD-L1 based on a BMS-8-modified gold electrode 2021 ·Bioelectrochemistry ·Paweł Niedziałkowski, (unknown), Jacek Ryl, (unknown), Marta Spodzieja, Katarzyna Magiera‐Mularz, Katarzyna Guzik, Grzegorz Dubin, Tad A. Holak, Tadeusz Ossowski, Sylwia Rodziewicz‐Motowidło	20
2	Development of the Inhibitors That Target the PD-1/PD-L1 Interaction—A Brief Look at Progress on Small Molecules, Peptides and Macrocycles 2019 ·Molecules ·Katarzyna Guzik, Marcin D. Tomala, (unknown), (unknown), (unknown), (unknown), (unknown), Roberto Butera, Alexander Dömlingꝉ, Tad A. Holak	114
3	NMR fragment-based screening for development of the CD44-binding small molecules 2018 ·Bioorganic Chemistry ·(unknown), (unknown), (unknown), Ewa Surmiak, Marcin D. Tomala, Aleksandra Twarda‐Clapa, Katarzyna Guzik, Grzegorz M. Popowicz, Tad A. Holak	4
4	A patent review on PD-1/PD-L1 antagonists: small molecules, peptides, and macrocycles (2015-2018) 2018 ·Expert Opinion on Therapeutic Patents ·Shabnam Shaabani, (unknown), Roberto Butera, (unknown), Katarzyna Guzik, Katarzyna Magiera‐Mularz, Tad A. Holak, Alexander Dömlingꝉ	116
5	PO-432 Small molecules, peptides and antibodies – the comparison of PD-1/PD-L1 blocking potential in an in vitro immune checkpoint blockade assay 2018 ·ESMO Open ·Łukasz Skalniak, Justyna Kocik-Krol, Katarzyna Guzik, Grzegorz Dubin, Tad A. Holak	3
6	1,4,5-Trisubstituted Imidazole-Based p53–MDM2/MDMX Antagonists with Aliphatic Linkers for Conjugation with Biological Carriers 2017 ·Journal of Medicinal Chemistry ·Aleksandra Twarda‐Clapa, (unknown), (unknown), Katarzyna Guzik, (unknown), Constantinos G. Neochoritis, Kareem Khoury, (unknown), (unknown), Grzegorz Dubin, Alexander Dömlingꝉ, Łukasz Skalniak, Tad A. Holak	27
7	Small-molecule inhibitors of PD-1/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cells 2017 ·Oncotarget ·Łukasz Skalniak, Krzysztof M. Żak, Katarzyna Guzik, Katarzyna Magiera‐Mularz, Bogdan Musielak, Magdalena Pachota, (unknown), Justyna Kocik-Krol, P. Grudnik, Marcin D. Tomala, (unknown), Krzysztof Pyrć, Alexander Dömlingꝉ, Grzegorz Dubin, Tad A. Holak	221
8	Small-Molecule Inhibitors of the Programmed Cell Death-1/Programmed Death-Ligand 1 (PD-1/PD-L1) Interaction via Transiently Induced Protein States and Dimerization of PD-L1 2017 ·Journal of Medicinal Chemistry ·Katarzyna Guzik, Krzysztof M. Żak, P. Grudnik, Katarzyna Magiera‐Mularz, Bogdan Musielak, Ricarda Törner, Łukasz Skalniak, Alexander Dömlingꝉ, Grzegorz Dubin, Tad A. Holak	271
9	Structural basis for small molecule targeting of the programmed death ligand 1 (PD-L1) 2016 ·Oncotarget ·Krzysztof M. Żak, P. Grudnik, Katarzyna Guzik, Bartosz J. Zieba, Bogdan Musielak, Alexander Dömlingꝉ, Grzegorz Dubin, Tad A. Holak	329
10	Structure of the Complex of Human Programmed Death 1, PD-1, and Its Ligand PD-L1 breakdown → 2015 ·Structure ·Krzysztof M. Żak, Radosław Kitel, Sara Przetocka, Przemysław Golik, Katarzyna Guzik, Bogdan Musielak, Alexander Dömlingꝉ, Grzegorz Dubin, Tad A. Holak	413
11	Fragment-Based Library Generation for the Discovery of a Peptidomimetic p53-Mdm4 Inhibitor 2014 ·ACS Combinatorial Science ·(unknown), Yijun Huang, (unknown), (unknown), Siglinde Wolf, (unknown), (unknown), Katarzyna Guzik, Tad A. Holak, Alexander Dömlingꝉ	12
12	Thermal transformations of Cu–Mg (Zn)–Al(Fe) hydrotalcite-like materials into metal oxide systems and their catalytic activity in selective oxidation of ammonia to dinitrogen 2013 ·Journal of Thermal Analysis and Calorimetry ·Magdalena Jabłońska, Lucjan Chmielarz, Agnieszka Węgrzyn, Katarzyna Guzik, Zofia Piwowarska, Stefan Witkowski, Richard I. Walton, Peter W. Dunne, František Kovanda	41
13	Cigarette smoke-exposed neutrophils die unconventionally but are rapidly phagocytosed by macrophages 2011 ·Cell Death and Disease ·Katarzyna Guzik, (unknown), (unknown), Monika Bzowska, B Gajkowska, David A. Scott, Jan Potempa	46
14	A new insight into phagocytosis of apoptotic cells: proteolytic enzymes divert the recognition and clearance of polymorphonuclear leukocytes by macrophages 2006 ·Cell Death and Differentiation ·Katarzyna Guzik, Monika Bzowska, (unknown), (unknown), (unknown), James Travis, Jan Potempa	48
15	Differential responses of hematopoietic and non-hematopoietic cells to anti-inflammatory cytokines: IL-4, IL-13 and IL-10. 2000 ·PubMed ·(unknown), Krystyna Stalińska, Katarzyna Guzik, Aleksander Koj	10
16	Vaccinia virus‐regulated acute phase cytokine production in human fibroblasts, U937 cells and endothelium 1998 ·Mediators of Inflammation ·Hanna Rokita, Tomasz Kupiec, Katarzyna Guzik, Aleksander Koj	9
17	Apoptosis of monocytes and prolonged survival of granulocytes as a result of phagocytosis of bacteria 1996 ·Infection and Immunity ·Jarosław Baran, Katarzyna Guzik, Waleria Hryniewicz, Martin Ernst, H.‐D. Flad, J Pryjma	102
18	Morris hepatoma 7777 cells produce autocrine growth inhibiting factor(s) 1990 ·Folia Histochemica et Cytobiologica ·Katarzyna Guzik, Andrzej Klein	1
19	Transforming growth factor-β1 stimulates proliferation of Morris hepatoma cells in serum-free soft agar culture system supplemented with EGF and insulin 1990 ·Cancer Letters ·Katarzyna Guzik, Andrzej Klein	3
20	On the autocrine growth regulation of Morris hepatoma cells. 1989 ·PubMed ·Katarzyna Guzik, Andrew Klein	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact